Elevated Capital Advisors’s Zoetis ZTS Stock Holding History

Elevated Capital Advisors’s Portfolio ZTS Stock Details ZTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.14K	Sell	35 -25	-42%	-$3.09K	﹤0.01%	566
2025 Q4	$7.55K	Buy	+60	New	+$7.83K	﹤0.01%	476
2022 Q4	–	Sell	-7,758	Closed	-$1.15M	–	175
2022 Q3	$1.15M	Buy	+7,758	New	+$1.3M	0.45%	80
2022 Q1	$1.5M	Buy	+7,971	New	+$1.58M	0.5%	59
2021 Q3	$1.56M	Buy	+8,022	New	+$1.62M	0.54%	53
2021 Q1	$1.2M	Buy	7,088 +563	+9%	+$89.2K	0.46%	74
2020 Q4	$1.08M	Buy	6,525 +462	+8%	+$75.1K	0.47%	67
2020 Q3	$986K	Sell	6,063 -1,027	-14%	-$158K	0.46%	68
2020 Q2	$1.17M	Buy	+7,090	New	+$926K	0.55%	59
2019 Q1	$519K	Buy	+4,190	New	+$380K	0.34%	100

Other funds holding ZTS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Elevated Capital Advisors's ZTS Position: Q1 2026 in Review

Elevated Capital Advisors reduced its Zoetis (ZTS) stake by 42% in Q1 2026, selling an estimated $3.09K and leaving 35 shares worth $4.14K. The position accounts for ﹤0.01% of the portfolio, ranked #566.

Elevated Capital Advisors first reported a position in ZTS in Q1 2019 and has held it in 10 quarters since. The position peaked at $1.56M in Q3 2021. 1,605 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

Elevated Capital Advisors held 35 shares of Zoetis worth $4.14K as of Q1 2026.
Elevated Capital Advisors sold 25 Zoetis shares in Q1 2026, an estimated $3.09K.
Zoetis made up ﹤0.01% of Elevated Capital Advisors's portfolio in Q1 2026, its #566 holding.
Elevated Capital Advisors first reported a position in Zoetis in Q1 2019 and has held it in 10 quarters since.
Elevated Capital Advisors's Zoetis position peaked at $1.56M in Q3 2021.
1,605 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Elevated Capital Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.